Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Generex Biotechnology Corp. (GNBTQ) Message Board

No one can prove the future, although we bet on th

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 36566
(Total Views: 365)
Posted On: 06/10/2021 11:00:39 PM
Posted By: rjs9787
Re: Pokey123 #30156
No one can prove the future, although we bet on the outcomes. Joe was dealt a lousy hand just as he was set to launch Excellagen in VA hospitals and open his vision of health clinics. And now, with Malaysia in an iron fist lockdown, Excellagen probably was dealt another temporary set back, although I’m not sure about that. Yet in the US, those VA hospitals and centers are reopening to full care. So the timeline for proving Excellagen worth as an investment is starting now into the 10 k in October and the subsequent Q. The Q in June shows the prior period so nothing happened then. But if nothing noteworthy is in the subsequent two filings I’d be surprised. And I’d stop believing in Excellagen. The next six months are vital in establishing worth in any investment in Excellagen. Jmho

——

Terry Thompson Gnbt CC May 2021
“I have been informed, with a high degree of confidence, that a current investor, is in the final stages of a financial commitment toward our restart. This investment will be used to re-establish our sales program for Excellagen on several fronts. Upon closing of this financing, we will complete our current bulk inventory. This will produce over 20,000 syringes which has a revenue potential of tens of millions of dollars. As the VA hospitals begin to re-open, we are positioned with a best-in-class product to methodically offer our wound healing product with our new international partners & building our brand starting with the VA hospital network.””


(4)
(0)




Generex Biotechnology Corp. (GNBTQ) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us